In a large randomized trial of adolescent girls, one dose of either the bivalent or nonavalent human papillomavirus (HPV) ...
A phase 1, open-label, dose expansion cohort of the tolerability of tolododekin alfa (ANK-101) in combination with cemiplimab in cutaneous squamous cell carcinoma. Phase I dose escalation and ...
The Trump administration plans to impose a new testing requirement for new vaccines — a demand that could delay the availability of the next round of COVID-19 vaccines and complicate the approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback